BIFIDOBACTERIUM BIFIDUM STRAIN POSSESSING GALACTOSIDASE ACTIVITY, GALACTOOLIGOSACCHARIDE COMPOSITION FOR STIMULATION OF BIFIDOBACTERIUM GROWTH, SYNBIOTIC COMPOSITION FOR IMPROVING BOWEL STATE, THEIR USING (VARIANTS) FOR PREPARING MEDICINAL PREPARATION AND METHOD FOR PREPARING BIFIDOBACTERIUM GROWTH STIMULATING AGENT Russian patent published in 2007 - IPC C12N1/20 C12P19/14 A61P1/04 C12R1/01 

FIELD: microbiology, biotechnology, biochemistry.

SUBSTANCE: invention relates to the Bifidobacterium bifidum NCIMB 41171 strain that elicits capacity for producing enzyme possessing galactosidase activity that converts lactose to a mixture of galactooligosaccharides comprising disaccharide, trisaccharide, tetrasaccharide and pentasaccharide. Galactooligosaccharide composition is designated for stimulation of bifidobacteria growth. Synbiotic composition based on B. bifidum NCIMB 41171 strain and galactooligosaccharide composition provides improvement in the bowel state. Compositions can be added to multiple foodstuffs and fodders for animals for improving bowel state by stimulation of bifidobacteria growth in large intestine and for inhibition of pathogenic microflora.

EFFECT: improved and valuable properties of strain.

20 cl, 2 dwg, 7 tbl, 7 ex